Since its establishment, the Center has trained a batch of tumor prevention and treatment professionals for South China and even the whole country, and has also made contributions to the construction of teaching materials: Clinical Oncology edited by Professor Wanderson of the Center has been listed as the national college planning teaching material in the Eleventh Five-Year Plan of the Ministry of Education; The postgraduate textbook Oncology, edited by Professor Zeng Yixin, was approved by the Ministry of Health as the national planning textbook in the 11th Five-Year Plan. Professor Huang Wenlin edited Molecular Virology, a national postgraduate planning textbook. Professor Jiang, Professor Zhang Xiaoshi edited the first tumor biotherapy in China. In 2004, the center held the first national excellent course for postgraduate students in oncology; In 2005, the center took the lead in exploring the training of oncologists in China, and actively explored the integration of specialist training in affiliated hospitals of universities and postgraduate education in clinical medicine.
The center is actively preparing to build a first-class underground radiotherapy center and west building in Asia to provide better and better services for cancer patients at home and abroad. The Center has established a grand blueprint for building itself into an oncology teaching and research base with the strongest comprehensive strength in China and international influence, and has been intensively carrying out the corresponding "three major projects" of management, information and infrastructure, and "honesty, friendship, dedication and innovation". Today's cancer prevention and treatment center will continue to uphold this spirit and seek the dream journey of mankind to conquer cancer!
Doctor profile
Brief introduction of Dr. Ma Jun
Master tutor. 1985 graduated from Hunan medical college with a bachelor's degree in medicine, and 1990 obtained a master's degree in clinical oncology from Zhongshan medical university. From 2000 to 2002, he received training at the M.D. Anderson Cancer Center of the University of Texas. She has been engaged in medical treatment, scientific research and teaching in our center, and has rich experience in the diagnosis and clinical treatment of nasopharyngeal carcinoma and head and neck tumors.
Brief introduction of Dr. Liu
Social part-time: Member of the Professional Committee of Cancer Pain Relief and Rehabilitation of Guangdong Anti-cancer Association.
Main direction and specialty: (1) Comprehensive radiotherapy for malignant tumors, with some experience in early diagnosis of head and neck tumors such as nasopharyngeal carcinoma, radiotherapy and chemotherapy, and comprehensive radiotherapy for chest and abdomen tumors such as primary liver cancer. (2) Clinical application research of radiosensitizers and malignant tumors, and participated in and was responsible for clinical trials of various new anticancer drugs.
Brief introduction of Dr. Hu
Graduated from the Medical Department of Sun Yat-sen Medical College, he has been engaged in medical treatment, scientific research and teaching in the radiotherapy department of Sun Yat-sen University Cancer Hospital for 30 years, and has rich clinical experience. He is good at radiotherapy of various malignant tumors, especially at using modern science and technology to treat nasopharyngeal carcinoma and malignant tumors of nasal cavity and paranasal sinuses. His research interests include nasopharyngeal carcinoma complicated with dermatomyositis, visual impairment caused by radiotherapy and clinical T-new staging of nasal cancer. He has published more than 40 academic articles at home and abroad and undertaken many scientific research projects.
Study on the damage of optic tract function caused by radiotherapy for nasopharyngeal carcinoma. Hu, Huang Shizhou, Wu Dezheng, et al. Chinese Journal of Radiation Oncology, 1995, April): 150- 153. 1996 won the second prize of young and middle-aged scientific papers of Sun Yat-sen Medical University.
Brief introduction of Dr. Guan Xunxing
195 1 Born in Indonesia, graduated from Zhongshan Medical University in Guangzhou. Deputy secretary of the Party branch of Radiotherapy Department, postgraduate tutor.
After graduating from Sun Yat-sen University of Medical Sciences, he stayed in the school and worked in the radiotherapy center for nearly 30 years. He has accumulated rich clinical experience and trained many graduate students. I have been responsible for the radiotherapy of breast cancer since the center implemented the single-disease diagnosis and treatment standard and the single-disease expert responsibility system, and presided over the compilation of the "Guidelines for Radiotherapy of Breast Cancer for Undergraduates". More than 700 cases of breast cancer have been treated. Responsible for the pretreatment of hematopoietic stem cell transplantation-whole body irradiation research 10 years. There are water tanks, ionization chambers, "China humanoid"-heterogeneous equivalent irradiation phantom, multi-channel semiconductor dosimeters and so on. Advanced instruments required for whole body irradiation and a group of skilled research team members, and received cases from almost all major hospitals in Guangzhou. The center's total body irradiation technology is in a leading position in the province.
Brief introduction of Dr. Chen Kai
1956 Born in Nantong City, Jiangsu Province in February, he is the director of outpatient department of Cancer Hospital of Sun Yat-sen University, the chief physician of radiotherapy department, the member of Cancer Branch of Guangdong Medical Association, and the member of the Standing Committee of Guangdong Society of Integrated Traditional Chinese and Western Medicine.
1982 12 graduated from Beijing university of Chinese medicine with a bachelor's degree and engaged in clinical medical work. 1989 graduated with a master's degree in medicine, and has been engaged in tumor radiotherapy since then. He is good at radiotherapy and comprehensive treatment of malignant tumors and has rich clinical experience. He has won more than one scientific and technological achievement award 10 from the whole army and Guangdong province, and published more than 20 papers. 1997 cooperated with the Foundation Department of Guangzhou University of Traditional Chinese Medicine to apply for the National Natural Science Foundation "The Relationship between Heat Shock Protein 70 Gene Expression in Different Malignant Tumors and Heat Syndrome in Traditional Chinese Medicine" and was funded. He was the second person in charge of the 39770889 project. Study on Prevention and Treatment of Radiation-induced Bone Marrow Injury with Chinese Medicine Monomer and Observation on Long-term Efficacy of Low-dose Whole Body Radiotherapy for Myasthenia Gravis Patients; In 2002, he was funded by the Military Hospital Fund and was the first person in charge of the project. Participated in the application for the Guangdong Provincial Health Department Fund 200 1 funded project "Study on the Bioreactor of Human Fibrinogen Activator".
Brief introduction of Dr. Lu Taixiang
Graduated from Sun Yat-sen University of Medical Sciences, he is currently the deputy director of cancer prevention and treatment center, cancer hospital, department, radiation oncology department and chief physician. Guangdong medical journal evaluation expert, family doctor magazine evaluation expert, Guangdong Natural Science Foundation Committee technical consultation evaluation expert, Guangzhou Science and Technology Bureau technical consultation evaluation expert.
Main direction, specialty and contribution:
(1) main direction: mainly engaged in clinical and scientific research work of radiotherapy for head and neck tumors.
(2) Expertise: radiotherapy for nasopharyngeal carcinoma and intensity modulated radiotherapy for head and neck tumors.
(3) Contribution: Engaged in clinical work of radiation oncology for more than 20 years, mainly engaged in radiotherapy of head and neck tumors, with emphasis on radiotherapy of nasopharyngeal carcinoma. He has participated in the key scientific research projects of the State Science and Technology Commission on July 5th and August 5th, undertaken the construction of the key laboratory for prevention and treatment of nasopharyngeal carcinoma in Guangdong Province and the clinical research projects, and established the radiotherapy standard for nasopharyngeal carcinoma in our department. 200 1, 1, "intensity modulated radiation therapy" was introduced for the first time in South China, and the conventional segmentation method of this technology was applied for the first time in China to treat nasopharyngeal carcinoma, and good results were achieved. He has participated in four international conferences on radiation oncology in the United States and Australia, and made two speeches at the conferences, reading and discussing papers on new radiotherapy technologies and intensity modulated radiotherapy for nasopharyngeal carcinoma.